|
Index of reports
> Cases resulting in other serious reactions (11)
Below is the selection of adverse event reports related to Abraxane (Paclitaxel) that includes cases resulting in other serious reactions.
Adverse event in 49 year old female receiving Abraxane (Paclitaxel)
Reported by a pharmacist from United States on 2007-10-18
Patient: 49 year old female, weighing 86.0 kg (189.2 pounds)
Adverse reactions / side effects: Rash Maculo-Papular
Suspect drug(s):
Abraxane
Dosage: 286mg weekly iv
Indication: Metastatic Malignant Melanoma
Start date: 2007-10-03
Abraxane
Dosage: 286mg weekly iv
Indication: Metastatic Malignant Melanoma
Start date: 2007-10-10
Adverse event in 40 year old female receiving Abraxane (Paclitaxel)
Reported by a pharmacist from United States on 2007-10-18
Patient: 40 year old female, weighing 109.0 kg (239.8 pounds)
Adverse reactions / side effects: Drug Hypersensitivity, Type IV Hypersensitivity Reaction, Erythema Multiforme
Suspect drug(s):
Abraxane
Dosage: 210 mg once iv
Indication: Metastatic Malignant Melanoma
Start date: 2007-09-10
Abraxane
Dosage: 210 mg once iv
Indication: Metastatic Malignant Melanoma
Start date: 2007-09-12
Abraxane
Dosage: 210 mg once iv
Indication: Metastatic Malignant Melanoma
Start date: 2007-09-19
Adverse event in 55 year old female receiving Abraxane (Paclitaxel)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-02
Patient: 55 year old female
Adverse reactions / side effects: Chills, Pyrexia, Eye Infection, Jugular Vein Thrombosis, Stevens-Johnson Syndrome, Blister, Cough, Vomiting, Rash Generalised, Stomatitis, Nausea, Anaemia, Hypotension, Staphylococcal Sepsis, Convulsion, Diarrhoea, Staphylococcal Infection
Adverse event resulted in: hospitalization
Suspect drug(s):
Nexavar
Dosage: total daily dose: 400 mg unit dose: 200 mg
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2006-09-01
End date: 2006-11-07
Nexavar
Dosage: total daily dose: 800 mg unit dose: 200 mg
Administration route: Oral
Start date: 2006-08-14
End date: 2006-09-01
Pyridoxine (Vitamin B6)
Indication: Drug USE FOR Unknown Indication
Vancomycin
Indication: Staphylococcal Infection
Abraxane
Indication: Malignant Melanoma
Carboplatin
Indication: Malignant Melanoma
Other drugs received by patient: Coumadin; Atenolol; Hydroxizine
Adverse event in female receiving Abraxane (Paclitaxel)
Reported by a pharmacist from United States on 2007-07-23
Patient: female, weighing 113.9 kg (250.5 pounds)
Adverse reactions / side effects: Neuropathy Peripheral, Nail Disorder, Adverse Event, Feeling of Body Temperature Change, Sensitivity of Teeth
Suspect drug(s):
Abraxane
Dosage: 220 mg 3 wks on, 1 wk off iv
Indication: Breast Cancer Metastatic
Start date: 2006-11-29
End date: 2007-07-01
Aranesp
Dosage: 100 mg qweek sq
Indication: Anaemia
Start date: 2005-11-18
End date: 2007-07-01
Aranesp
Dosage: 100 mg qweek sq
Indication: Chemotherapy
Start date: 2005-11-18
End date: 2007-07-01
Adverse event in 49 year old female receiving Abraxane (Paclitaxel)
Reported by a pharmacist from United States on 2007-06-14
Patient: 49 year old female, weighing 74.8 kg (164.7 pounds)
Adverse reactions / side effects: Cellulitis, Tongue Ulceration, Febrile Neutropenia, LIP Ulceration, Skin Ulcer, Oedema Peripheral, Neutropenia, Lymphoedema
Suspect drug(s):
Avastin
Dosage: iv (2nd cycle)
Indication: Breast Cancer Metastatic
Abraxane
Dosage: iv (2nd cycle)
Indication: Breast Cancer Metastatic
Other drugs received by patient: Hydromorphone HCL; Ativan; Diflucan; Rocephin; Famvir
Adverse event in female receiving Abraxane (Paclitaxel)
Reported by a physician from United States on 2007-05-14
Patient: female
Adverse reactions / side effects: Arthralgia, Dehydration, Rash Maculo-Papular
Suspect drug(s):
Avastin
Dosage: 1100 mg, unk
Indication: Breast Cancer
Start date: 2007-01-26
End date: 2007-03-28
Abraxane
Dosage: 551 mg, unk
Indication: Breast Cancer
Start date: 2007-03-21
End date: 2007-03-28
Adriamycin PFS
Dosage: 127 mg, 2/month
Indication: Rash
Start date: 2007-01-26
Cytoxan
Dosage: 1272 mg, 2/month
Indication: Drug USE FOR Unknown Indication
Start date: 2007-01-26
Neulasta
Dosage: 6 mg, unk
Indication: Drug USE FOR Unknown Indication
Start date: 2007-01-27
Other drugs received by patient: Prevacid; Simvastatin; Lexapro; Peridex Mouthwash; Tylenol W / Codeine; Compazine; Emend; Benadryl
Adverse event in 56 year old male receiving Abraxane (Paclitaxel)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-14
Patient: 56 year old male
Adverse reactions / side effects: Bronchopleural Fistula, Neutropenia, Hydropneumothorax
Adverse event resulted in: life threatening event
Suspect drug(s):
Paraplatin
Dosage: 1st dose: 29mar2005. add'l lot #'s: 4cb4529 (exp. 01dec2005), 4d77477 (exp. 01feb2006)
Indication: non-Small Cell Lung Cancer
Start date: 2005-04-26
End date: 2005-04-26
Abraxane
Indication: non-Small Cell Lung Cancer
Start date: 2005-04-26
End date: 2005-04-26
Other drugs received by patient: Cefoperazone Sodium+sulbactam; Polyvidone
Adverse event in 74 year old female receiving Abraxane (Paclitaxel)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-11
Patient: 74 year old female, weighing 63.8 kg (140.3 pounds)
Adverse reactions / side effects: Flushing, Pruritus, Dyspnoea, Nausea, Blood Pressure Decreased, Feeling Abnormal
Suspect drug(s):
Abraxane (Paclitaxel)
Other drugs received by patient: Nexium; Actos; Zetia; Fosamax; Neurontin
Adverse event in female receiving Abraxane (Paclitaxel)
Reported by a physician from United States on 2007-04-19
Patient: female
Adverse reactions / side effects: Rash Maculo-Papular
Suspect drug(s):
Avastin
Dosage: 1100 mg, unk
Indication: Breast Cancer
Start date: 2007-01-26
End date: 2007-03-28
Abraxane
Dosage: 551 mg, unk
Indication: Breast Cancer
Start date: 2007-03-21
End date: 2007-03-28
Adriamycin PFS
Dosage: 127 mg, 2/month
Indication: Rash
Start date: 2007-01-26
Cytoxan
Dosage: 1272 mg, 2/month
Indication: Drug USE FOR Unknown Indication
Start date: 2007-01-26
Neulasta
Dosage: 6 mg, unk
Indication: Drug USE FOR Unknown Indication
Start date: 2007-01-27
Other drugs received by patient: Prevacid; Simvastatin; Lexapro; Peridex Mouthwash; Tylenol W / Codeine; Compazine; Emend; Benadryl
Adverse event in 64 year old female receiving Abraxane (Paclitaxel)
Reported by a consumer/non-health professional from United States on 2007-04-17
Patient: 64 year old female, weighing 68.0 kg (149.7 pounds)
Adverse reactions / side effects: Chest Discomfort, Dyspnoea, Paresis, Urinary Incontinence, Faecal Incontinence, Hypoaesthesia, Arthropathy, Alopecia, Feeling Abnormal
Suspect drug(s):
Abraxane (Paclitaxel)
Adverse event in female receiving Abraxane (Paclitaxel)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-02-16
Patient: female, weighing 91.9 kg (202.2 pounds)
Adverse reactions / side effects: White Blood Cell Count Decreased, Neutropenia
Suspect drug(s):
Doxorubicin HCL
Dosage: 60 mg/m2 q 2 weeks 4 cycles iv
Indication: Chemotherapy
Start date: 2006-09-21
End date: 2006-11-02
Cyclophosphamide
Dosage: 600 mg/m2 q 2 weeks 4 cycles iv
Indication: Chemotherapy
Start date: 2006-09-21
End date: 2006-11-02
Abraxane
Dosage: 260 mg/m2 q 2 weeks 4 cycles iv
Indication: Chemotherapy
Start date: 2006-11-16
End date: 2006-12-28
Other drugs received by patient: Ativan; Compazine and Decadron; Nystatin
|
